33 results on '"Ambrosio, Luigina"'
Search Results
2. Reduction of the risk of severe COVID-19 due to Omicron compared to Delta variant in Italy (November 2021 – February 2022)
3. Antimicrobial susceptibility profiles and genotyping of Neisseria meningitidis of serogroup C, Italy, 2000–2020
4. Carriage meningococcal isolates with capsule null locus dominate among high school students in a non-endemic period, Italy, 2012–2013
5. Selective Pressure and Evolution of SARS-CoV-2 Lineages BF.7 and BQ.1.1 Circulating in Italy from July to December 2022.
6. The “Investigating and translating genomic evidence for public health response to SARS-CoV-2 (INSIDE SARS-CoV-2)” project – Network of excellence.
7. Seven Years of Culture Collection of Neisseria gonorrhoeae: Antimicrobial Resistance and Molecular Epidemiology
8. Tracking the Selective Pressure Profile and Gene Flow of SARS-CoV-2 Delta Variant in Italy from April to October 2021 and Frequencies of Key Mutations from Three Representative Italian Regions.
9. FHbp variants among meningococci of serogroup B in Italy: Evolution and selective pressure, 2014–2017
10. Seven Years of Culture Collection of Neisseria gonorrhoeae: Antimicrobial Resistance and Molecular Epidemiology
11. Tracking the progressive spread of the SARS-CoV-2 Omicron variant in Italy, December 2021 to January 2022
12. SARS-CoV-2 variants: what have we learnt so far? Commentary
13. Primary septic arthritis of the knee caused by Neisseria meningitidis serogroup B in an elderly patient. Case report and review of the literature
14. Reactive vaccination as control strategy for an outbreak of invasive meningococcal disease caused by Neisseria meningitidis C:P1.5-1,10-8:F3-6:ST-11(cc11), Bergamo province, Italy, December 2019 to January 2020
15. Evaluation of Meningococcal Serogroup C Bactericidal Antibodies after Primary Vaccination: A Multicentre Study, Italy
16. Did social distancing measures deployed for SARS-CoV-2/COVID-19 control have an impact on invasive meningococcal disease?
17. Protective Role of Combined Polyphenols and Micronutrients against Influenza A Virus and SARS-CoV-2 Infection In Vitro
18. Molecular characterisation and antibiotic susceptibility of meningococcal isolates from healthy men who have sex with men
19. Molecular characterisation and antibiotic susceptibility of meningococcal isolates from healthy men who have sex with men.
20. Cross-reactivity of 4CMenB vaccine-induced antibodies against meningococci belonging to non-B serogroups in Italy
21. Evaluation of the national surveillance system for invasive meningococcal disease, Italy, 2015–2018
22. SARS-CoV-2 variants: what have we learnt so far?
23. Estimates of the reproductive numbers and demographic reconstruction of outbreak associated with C:P1.5–1,10–8:F3–6:ST–11(cc11) Neisseria meningitidis strains
24. Reconstruction of Dispersal Patterns of Hypervirulent Meningococcal Strains of Serogroup C:cc11 by Phylogenomic Time Trees
25. Did social distancing measures deployed for SARS-CoV-2/COVID-19 control have an impact on invasive meningococcal disease?
26. Invasive meningococcal disease due to ciprofloxacin-resistant Neisseria meningitidis Sequence Type 7926: the first case in Italy, likely imported
27. Genomic analysis of Neisseria meningitidis carriage isolates during an outbreak of serogroup C clonal complex 11, Tuscany, Italy
28. Gene flow and Bayesian phylogeography of serogroup C meningococci circulating in Italy.
29. Neisseria meningitidis Antimicrobial Resistance in Italy, 2006 to 2016
30. Invasive meningococcal disease due to ciprofloxacin-resistant Neisseria meningitidisSequence Type 7926: the first case in Italy, likely imported
31. An outbreak of COVID-19 after a pilgrimage to Medjugorje due to Delta sublineages.
32. Neisseria meningitidisAntimicrobial Resistance in Italy, 2006 to 2016
33. Gene flow and Bayesian phylogeography of serogroup C meningococci circulating in Italy.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.